These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21495226)

  • 1. Part 2: Ovarian failure in adolescent cancer survivors should be treated.
    Hershlag A; Rausch ME; Cohen M
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):101-3. PubMed ID: 21495226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk?
    Fish JD
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98-101. PubMed ID: 21495224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.
    Gargus E; Deans R; Anazodo A; Woodruff TK
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1137-1149. PubMed ID: 30181423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.
    Mulder JE
    Med Pediatr Oncol; 1999 Jul; 33(1):46-52. PubMed ID: 10401497
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring ovarian function in young cancer survivors.
    Su HI
    Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure.
    Gelbaya T; Vitthala S; Nardo L; Seif M
    Gynecol Endocrinol; 2011 Jan; 27(1):1-7. PubMed ID: 20608810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: Should ovarian failure in survivors of childhood cancers be treated with hormonal therapy?
    Appelbaum H
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):98. PubMed ID: 21495223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
    Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian effects of radiation and cytotoxic chemotherapy damage.
    Cosgrove CM; Salani R
    Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():37-48. PubMed ID: 30166215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.
    Chemaitilly W; Li Z; Krasin MJ; Brooke RJ; Wilson CL; Green DM; Klosky JL; Barnes N; Clark KL; Farr JB; Fernandez-Pineda I; Bishop MW; Metzger M; Pui CH; Kaste SC; Ness KK; Srivastava DK; Robison LL; Hudson MM; Yasui Y; Sklar CA
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2242-2250. PubMed ID: 28368472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Committee opinion no. 502: primary ovarian insufficiency in the adolescent.
    Obstet Gynecol; 2011 Sep; 118(3):741-745. PubMed ID: 21860315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone supplementation for pubertal induction in girls.
    Matthews D; Bath L; Högler W; Mason A; Smyth A; Skae M
    Arch Dis Child; 2017 Oct; 102(10):975-980. PubMed ID: 28446424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic fibroids in two patients on hormone replacement therapy with primary ovarian failure secondary to prepubertal gonadotoxic cancer treatment.
    Kalra SK; Gracia CR; Barnhart KT
    J Womens Health (Larchmt); 2008; 17(6):1035-7. PubMed ID: 18554096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
    Sullivan SD; Sarrel PM; Nelson LM
    Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms' tumor treated with radiotherapy.
    Nussbaum Blask AR; Nicholson HS; Markle BM; Wechsler-Jentzch K; O'Donnell R; Byrne J
    AJR Am J Roentgenol; 1999 Mar; 172(3):759-63. PubMed ID: 10063876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian tissue cryopreservation in girls].
    Poirot C; Guerin F; Yakouben K; Prades M; Martelli H; Brugieres L
    Bull Acad Natl Med; 2013; 197(4-5):887-98. PubMed ID: 25518157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.